13-Methyl-6-methylene-4,8-di(p-toluenesulfonyl)-4,8,15-triazabicyclo[9.3.1]pentadeca-1(15),11,13-triene Hydrochloride

ID: ALA4785236

Chembl Id: CHEMBL4785236

PubChem CID: 162666703

Max Phase: Preclinical

Molecular Formula: C28H34ClN3O4S2

Molecular Weight: 539.72

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1CN(S(=O)(=O)c2ccc(C)cc2)CCc2cc(C)cc(n2)CCN(S(=O)(=O)c2ccc(C)cc2)C1.Cl

Standard InChI:  InChI=1S/C28H33N3O4S2.ClH/c1-21-5-9-27(10-6-21)36(32,33)30-15-13-25-17-23(3)18-26(29-25)14-16-31(20-24(4)19-30)37(34,35)28-11-7-22(2)8-12-28;/h5-12,17-18H,4,13-16,19-20H2,1-3H3;1H

Standard InChI Key:  OFBWNMVBBYNTLW-UHFFFAOYSA-N

Associated Targets(Human)

CD4 Tclin T-cell surface antigen CD4 (114 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MT4 (17854 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 539.72Molecular Weight (Monoisotopic): 539.1912AlogP: 4.04#Rotatable Bonds: 4
Polar Surface Area: 87.65Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.72CX LogP: 4.70CX LogD: 4.70
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.47Np Likeness Score: -0.53

References

1. Lumangtad LA,Claeys E,Hamal S,Intasiri A,Basrai C,Yen-Pon E,Beenfeldt D,Vermeire K,Bell TW.  (2020)  Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds.,  28  (24): [PMID:33181479] [10.1016/j.bmc.2020.115816]

Source